A class of drugs called senolytics remove
Posted: Sun Feb 02, 2025 9:38 am
China is now poised to become the first major economy to issue a digital version of its money and eventually replace cash with it.
Chinese leaders see Libra as a threat because its reserve will be in dollars and could increase US influence in the global financial system. The publication believes that China intends to promote a “digital yuan” internationally to counter the role of the dollar as the world’s reserve currency.
Libra could become a geopolitical event and start a war for digital money: in October 2019, Facebook CEO Mark Zuckerberg promised Congress that Libra would “expand America’s financial leadership, as well as mexico number data democratic values and control around the world.”
Anti-aging drugs
Drugs that attempt to treat diseases by targeting the body's natural aging process have shown promise.
Why it matters: A list of different diseases, including cancer, heart disease, and dementia, could potentially be cured by slowing the aging process.
Key players: Unity Biotechnology, Alkahest, Mayo Clinic, Oisín Biotechnologies, Siwa Therapeutics.
Availability: less than 5 years.
The first wave of a new class of anti-aging drugs has begun human trials. They don't yet make you live longer, but are aimed at treating specific diseases by slowing or reversing the aging process at a fundamental level.
certain cells that accumulate with age and can cause inflammation, inhibit cell repair mechanisms, and create a toxic environment for neighboring cells.
In June 2019, San Francisco-based Unity Biotechnology reported initial results from a treatment for patients with mild to severe knee osteoarthritis, and results from a larger clinical trial are expected in the second half of 2020. The company is also developing similar drugs to treat age-related eye and lung diseases.
Senolytics are undergoing human trials alongside other promising approaches targeting the biological processes underlying aging and various age-related diseases.
For example, Alkahest is injecting patients with components unique to the blood of young people. The company believes this could halt cognitive and functional decline in patients with mild to moderate Alzheimer's disease. Alkahest is also testing drugs for Parkinson's disease and dementia in patients.
Chinese leaders see Libra as a threat because its reserve will be in dollars and could increase US influence in the global financial system. The publication believes that China intends to promote a “digital yuan” internationally to counter the role of the dollar as the world’s reserve currency.
Libra could become a geopolitical event and start a war for digital money: in October 2019, Facebook CEO Mark Zuckerberg promised Congress that Libra would “expand America’s financial leadership, as well as mexico number data democratic values and control around the world.”
Anti-aging drugs
Drugs that attempt to treat diseases by targeting the body's natural aging process have shown promise.
Why it matters: A list of different diseases, including cancer, heart disease, and dementia, could potentially be cured by slowing the aging process.
Key players: Unity Biotechnology, Alkahest, Mayo Clinic, Oisín Biotechnologies, Siwa Therapeutics.
Availability: less than 5 years.
The first wave of a new class of anti-aging drugs has begun human trials. They don't yet make you live longer, but are aimed at treating specific diseases by slowing or reversing the aging process at a fundamental level.
certain cells that accumulate with age and can cause inflammation, inhibit cell repair mechanisms, and create a toxic environment for neighboring cells.
In June 2019, San Francisco-based Unity Biotechnology reported initial results from a treatment for patients with mild to severe knee osteoarthritis, and results from a larger clinical trial are expected in the second half of 2020. The company is also developing similar drugs to treat age-related eye and lung diseases.
Senolytics are undergoing human trials alongside other promising approaches targeting the biological processes underlying aging and various age-related diseases.
For example, Alkahest is injecting patients with components unique to the blood of young people. The company believes this could halt cognitive and functional decline in patients with mild to moderate Alzheimer's disease. Alkahest is also testing drugs for Parkinson's disease and dementia in patients.